Difference between revisions of "Apligraf"

From IntactiWiki
Jump to navigation Jump to search
(Created page with "{{Construction Site}} right|thumb| Apligraf is a synthetic skin created from harvested foreskins.<ref> {{cite web | url = http://www.apligraf.com...")
 
m
Line 1: Line 1:
{{Construction Site}}
+
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] -->
 +
Apligraf is a synthetic skin created from harvested foreskins.<ref>{{REFwebQuote
 +
| quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins
 +
| last=
 +
| first=
 +
| publisher=Organogenesis
 +
| year=
 +
| urltitle=Apligraf: How Is It Made?
 +
| url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
 +
| accessdate=2011-03-06
 +
}}</ref> It is [[FDA]] approved,<ref>{{REFwebQuote
 +
| quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
 +
| last=
 +
| first=
 +
| publisher=Organogenesis
 +
| year=
 +
| urltitle=Apligraf
 +
| url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
 +
| accessdate=2011-03-06
 +
}}</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
  
[[Image:Alloderm-logo.jpg|right|thumb|]]
+
== Apligraph Oral ==
Apligraf is a synthetic skin created from harvested foreskins.<ref>
 
{{cite web
 
| url = http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/
 
| title = Apligraf: How Is It Made?
 
| accessdate = 2011-03-06
 
| publisher = Organogenesis
 
| quote = Human keratinocytes and fibroblasts are derived from neonatal foreskins
 
}}
 
</ref> It is [[FDA]] approved,<ref>
 
{{cite web
 
| url = http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html
 
| title = Apligraf
 
| accessdate = 2011-03-06
 
| publisher = Organogenesis
 
| quote = Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
 
}}
 
</ref> and it is made and sold by [[Organogenesis]], which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
 
  
==Apligraph Oral==
+
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews
 
+
| last=
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref> {{cite web | url = http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | title = November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | accessdate = 2011-12-20 | date = November 2011}}</ref>
+
| first=
 +
| coauthors=
 +
| url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf
 +
| title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript
 +
| date=November 2011
 +
| publisher=FDA
 +
| quote=
 +
| accessdate=2011-12-20
 +
}}</ref>
  
 
Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf
 
Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf
  
==<small>References</small>==
+
{{REF}}
<div class='references-small'>
 
<references/>
 
</div>
 
  
 
[[Category:Foreskin Products]]
 
[[Category:Foreskin Products]]

Revision as of 14:12, 18 August 2019

Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.

Apligraph Oral

Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]

Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf

References